Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...
Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...
A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...
The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...
Calorie restriction, physical activity and the drug dapagliflozin caused 44% of participants in a small trial to enter ...
Ozempic, the blockbuster GLP-1 drug that was originally ... about 5% in adults with both type 2 diabetes and chronic kidney disease, the company said in a news release. Chronic kidney disease ...